Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Verzenio (abemaciclib)
Pharma
Lilly logs huge Q4 revenue jump despite recent incretin letdown
Lilly reported fourth-quarter sales of $13.53 billion, a steep 45% increase over the sum it generated during the same stretch in 2023.
Fraiser Kansteiner
Feb 6, 2025 12:56pm
Kisqali off to a 'very rapid' launch in early breast cancer: CEO
Jan 31, 2025 11:28am
Novartis pressures Lilly with Kisqali's broad breast cancer nod
Sep 17, 2024 3:04pm
Lilly lifts guidance by $3B after strong GLP-1 performance
Aug 8, 2024 11:18am
ASCO: Lilly seeks prostate cancer redemption after Verzenio flop
May 23, 2024 5:00pm
Lilly’s growth drivers, Verzenio and Jardiance, suffer setbacks
Apr 30, 2024 10:48am
